The American Journal of Medical Sciences and Pharmaceutical Research
32
https://www.theamericanjournals.com/index.php/tajmspr
TYPE
Original Research
PAGE NO.
32-36
10.37547/tajmspr/Volume07Issue04-06
OPEN ACCESS
SUBMITED
16 February 2025
ACCEPTED
17 March 2025
PUBLISHED
16 April 2025
VOLUME
Vol.07 Issue04 2025
CITATION
Farida Azizova. (2025). Urbanization and declining air quality: clinical
aspects of cardiovascular impact. The American Journal of Medical
Sciences and Pharmaceutical Research, 7(04), 32
–
36.
https://doi.org/10.37547/tajmspr/Volume07Issue04-06
COPYRIGHT
© 2025 Original content from this work may be used under the terms
of the creative commons attributes 4.0 License.
Urbanization and declining
air quality: clinical aspects
of cardiovascular impact
Farida Azizova
Center for Professional Development of Medical Workers, Tashkent,
Uzbekistan
Abstract:
Rapid
urbanization
has
significantly
contributed to deteriorating air quality across global
cities. Increasing levels of air pollutants, particularly fine
particulate matter (PM2.5), nitrogen dioxide (NO₂), and
ozone (O₃), are linked to adverse cardiovascular
outcomes. This article explores the clinical implications
of declining air quality due to urbanization, reviewing
evidence from epidemiological and clinical studies and
analyzing the mechanisms through which air pollution
exacerbates cardiovascular disease. The findings
emphasize the urgent need for integrative public health
policies and clinical interventions to mitigate these risks.
Keywords:
Urbanization, Air Pollution, Cardiovascular
Disease (CVD), PM2.5, Nitrogen Dioxide (NO₂), Ozone
(O₃), Endothelial Dysfunction, Systemic Inflammation,
Hypertension, Myocardial Infarction, Environmental
Health, Public Health Policy.
Introduction:
Urbanization is one of the most significant
demographic shifts of the 21st century. As of 2024,
more than 56% of the world's population resides in
urban areas, and this is projected to increase to nearly
70% by 2050, according to United Nations estimates.
While urban living has many socio-economic
advantages
—
including better access to healthcare,
education, and employment
—
it also has environmental
and health challenges, especially the deterioration of air
quality.
Air pollution is a severe and unwanted accompaniment
of rapid and largely unchecked urbanization. Increased
vehicular emissions, industrial activities, construction,
and energy consumption are all significant contributing
factors to the release of dangerous pollutants into the
atmosphere. Some of the most harmful air pollutants in
cities are particulate matter (especially PM2.5), nitrogen
dioxide (NO₂), sulfur dioxide (SO₂), ozone (O₃), and
carbon monoxide (CO). These pollutants have human
The American Journal of Medical Sciences and Pharmaceutical Research
33
https://www.theamericanjournals.com/index.php/tajmspr
The American Journal of Medical Sciences and Pharmaceutical Research
health effects that are well characterized, with a
growing div of evidence incriminating cardiovascular
disease (CVD) as a leading clinical endpoint of long-
term and short-term exposure.
Cardiovascular disease remains the greatest killer
worldwide, and emerging evidence implicates air
pollution as a modifiable risk factor. Both acute and
chronic exposures to air pollutants have been
associated with increased incidence of hypertension,
atherosclerosis, myocardial infarction, heart failure,
arrhythmias, and stroke. Most vulnerable are the
elderly, individuals with underlying cardiovascular
disease, and residents of low- and middle-income
urban cities where pollution-reducing measures are
not typically in effect.
At the clinical level, the pathophysiological
mechanisms that link air pollution with cardiovascular
dysfunction include systemic inflammation, oxidative
stress, endothelial dysfunction, and autonomic
nervous system imbalance. Such biologic responses
are the predisposition to the development of CVD and
can be quantified using biomarkers such as C-reactive
protein (CRP), interleukins, and troponins.
While the issue has been broadly acknowledged, there
is a gap in the translation of environmental risk into
clinically relevant approaches. Understanding how
cardiovascular health is impacted by air pollution due
to urbanization is not just a requirement for public
health policy but also for clinical practice. Physicians,
city planners, and policymakers must work in tandem
with one another to address this new public health
menace.
The aim of this article is to review the clinical aspects
of cardiovascular disease in relation to worsening air
quality in cities. By summarizing the recent literature
and discussing the key mechanisms, outcomes, and
implications, this article aims to provide a general
overview of the urban air
–
cardiovascular health
connection.
METHODS
This study employed a systematic narrative literature
review to evaluate the clinical impact of deteriorating
air quality in urban areas on cardiovascular health.
Three major electronic databases
—
PubMed, Scopus,
and Web of Science
—
were systematically searched to
identify relevant articles. The search was conducted
from November 2024 to February 2025. Keywords and
Medical Subject Headings (MeSH) terms used in
combination were: "urbanization," "air pollution,"
"cardiovascular disease," "PM2.5," "nitrogen dioxide,"
"ozone," "clinical outcomes," "biomarkers," and
"environmental health."
The following were the inclusion criteria: (1) English
language studies from January 2015 through December
2024; (2) original research articles, meta-analyses, or
systematic reviews in peer-reviewed journals; (3) urban
population studies; (4) articles that provided
cardiovascular outcomes for ambient air pollution
exposure; and (5) studies on human subjects. Editorials,
opinion pieces, conference abstracts, and studies with a
primary outcome of interest as non-cardiovascular
health effects (e.g., respiratory or neurological effects
only) were excluded.
The search strategy followed the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) guidelines where applicable, although the
present study is not a formal systematic review (Page et
al., 2021). Duplicates were removed, and titles and
abstracts were screened independently by two
reviewers. Full-text papers of possibly relevant studies
were obtained and were reviewed in-depth to assess
their applicability to the study objective.
Selected studies were reviewed systematically for the
following major parameters:
• Type and concentration of air pollutants measured,
such a
s PM2.5, PM10, nitrogen dioxide (NO₂), sulfur
dioxide (SO₂), carbon monoxide (CO), and ozone (O₃), by
standard environmental monitoring techniques.
•
Study
population
and
setting
population
characteristics, with urban-rural comparisons where
applicable, and subgroup analyses by age, sex,
socioeconomic status, and pre-existing medical
conditions (Brook et al., 2010; Kaufman et al., 2016).
• Cardiovascular impacts, both acute (myocardial
infarction, arrhythmias, hypertensive crisis, etc.) and
chronic (heart failure, atherosclerosis, hypertension,
etc.), determined by validated clinical criteria and
hospital or public health databases (Rajagopalan et al.,
2018).
• Cardiovascular disease
-relevant clinical biomarkers,
such as high-sensitivity C-reactive protein (hs-CRP),
interleukin-6 (IL-6), B-type natriuretic peptide (BNP),
cardiac troponins, and blood pressure or heart rate
variability alterations (Pope et al., 2016).
• Mechanistic support from cohort studies, controlled
exposure studies, and population-based investigations
of inflammation, endothelial dysfunction, oxidative
stress, and autonomic imbalance as mediating pathways
of pollution-attributable cardiovascular damage (Newby
et al., 2015; Münzel et al., 2017).
RESULTS
67 related studies were considered relevant to the
research question with observational cohorts, cross-
sectional data, and controlled exposure trials conducted
The American Journal of Medical Sciences and Pharmaceutical Research
34
https://www.theamericanjournals.com/index.php/tajmspr
The American Journal of Medical Sciences and Pharmaceutical Research
in diverse urban environments. A common and
necessary finding in much of the literature is that the
urban air pollution
—
particularly low- and middle-
income country locations
—
is being observed at levels
way beyond World Health Organization's established
standards. Year-round average concentrations of fine
particulate matter (PM2.5) often varied between two
and ten times the safe level of 5 µg/m³, particularly in
megacities such as Delhi, Beijing, and Los Angeles
(World Health Organization, 2021; Brauer et al., 2016).
These elevated concentrations are mainly attributed to
motor vehicle emissions, industrial processes, and
fossil fuel burning for energy, compounded in densely
populated and rapidly urbanizing regions.
A number of large-scale epidemiological studies have
established a strong association between urban air
pollution
exposure
and
increased
rates
of
cardiovascular events. For instance, findings from the
Framingham Offspring Study demonstrated that short-
term exposure to high concentrations of PM2.5
considerably increased the risk of myocardial
infarction, with effects being observed within hours to
days following exposure (Wilker et al., 2013). Similarly,
Multi-Ethnic Study of Atherosclerosis (MESA Air) also
revealed that long-term exposure to nitrogen dioxide
(NO₂) and traffic
-related air pollution was associated
with the fast progression of coronary artery
calcification, indicating long-term vascular burden
(Kaufman et al., 2016).
Hypertension has also emerged as a critical outcome
linked to urban air pollution. Several studies observed
that chronic exposure to NO₂ and PM2.5 is associated
with both increased systolic and diastolic blood
pressure, suggesting vascular dysfunction and
increased peripheral resistance as underlying
mechanisms (Fuks et al., 2014; Yang et al., 2018). These
associations were more pronounced in older adults
and individuals with pre-existing cardiometabolic risk
factors.
Air pollution exposure also appears to exacerbate
heart failure and contribute to the onset of cardiac
arrhythmias. Emergency department visits and
hospitalizations for heart failure exacerbations have
been positively correlated with elevated levels of
ozone (O₃) and particulate matter, particularly during
heat waves or pollution spikes (Shah et al., 2013; Bell
et al., 2014). Arrhythmogenic effects, especially among
the elderly, have been linked to short-term
fluctuations in PM2.5 and ultrafine particles, likely
mediated through autonomic imbalance and increased
myocardial irritability.
At the molecular and clinical biomarker level, studies
consistently reported elevated concentrations of high-
sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-
6), fibrinogen, and cardiac troponins among individuals
exposed to high levels of ambient air pollution. These
biomarkers reflect a systemic inflammatory state and
endothelial activation, which are pivotal in the
development and destabilization of atherosclerotic
plaques (Brook et al., 2010; Pope et al., 2016).
Mechanistic insights from controlled human exposure
studies and animal models further support the notion
that air pollutants trigger oxidative stress, impair
endothelial nitric oxide signaling, and induce autonomic
dysregulation, ultimately increasing cardiovascular
vulnerability (Münzel et al., 2017; Newby et al., 2015).
Taken together, the evidence supports a strong and
biologically plausible link between urban air pollution
and adverse cardiovascular outcomes. The relationship
spans both acute and chronic exposures, involves
multiple pollutant types, and affects diverse urban
populations worldwide.
DISCUSSION
This review underscores the mounting evidence of a
significant and growing association between urban air
pollution and adverse cardiovascular outcomes.
Multiple studies from diverse geographical regions have
consistently shown that exposure to pollutants such as
particulate matter (PM2.5) and nitrogen dioxide (NO₂)
not only exacerbates pre-existing cardiovascular
conditions, but also contributes to the onset and
progression of cardiovascular disease. These findings
are supported by extensive epidemiological data and
experimental studies that indicate how chronic
exposure
to
these
pollutants
may
influence
cardiovascular health on both acute and long-term
scales. In particular, fine particulate matter (PM2.5),
which penetrates deeply into the respiratory system
and enters the bloodstream, has been implicated in
increasing the risk of conditions like myocardial
infarction, stroke, and heart failure (Pope et al., 2016;
Wilker et al., 2013). Nitrogen dioxide (NO₂) exposure,
often associated with traffic-related pollution, has been
found to contribute significantly to the development of
hypertension and atherosclerosis, both of which are
critical risk factors for cardiovascular diseases (Brook et
al., 2010; Yang et al., 2018).
The pathophysiological mechanisms behind these
associations are complex and involve several
interconnected
biological
pathways.
Endothelial
dysfunction, a hallmark of cardiovascular diseases, is a
key mechanism by which air pollutants influence
vascular health. Systemic inflammation, which is
triggered by exposure to airborne pollutants, has been
shown to initiate and exacerbate atherosclerotic
processes, leading to plaque formation and instability,
The American Journal of Medical Sciences and Pharmaceutical Research
35
https://www.theamericanjournals.com/index.php/tajmspr
The American Journal of Medical Sciences and Pharmaceutical Research
which can result in acute events like heart attacks and
strokes (Brook et al., 2010; Münzel et al., 2017).
Moreover, the dysregulation of autonomic functions
and oxidative stress further compounds the
cardiovascular risks associated with air pollution
(Newby et al., 2015). The evidence also points to the
fact that these harmful effects are not confined to
individuals with existing cardiovascular disease; even
healthy individuals exposed to high levels of pollution
show signs of vascular and systemic dysfunction.
Urban populations are particularly vulnerable to the
harmful effects of air pollution, especially in low- and
middle-income countries where pollution control
measures are often inadequate and access to
healthcare services may be limited. In these regions,
rapid urbanization, coupled with industrialization and
vehicle emissions, has resulted in alarming levels of air
pollutants, exacerbating public health concerns.
Furthermore, socioeconomic disparities often mean
that
marginalized
communities
bear
a
disproportionate burden of exposure, with limited
resources for mitigation or treatment of the resulting
health conditions (Brauer et al., 2016; WHO, 2021).
As clinicians, it is critical to recognize environmental
exposure as a modifiable cardiovascular risk factor. The
medical community should incorporate environmental
history into routine cardiovascular assessments,
especially for patients with pre-existing cardiovascular
conditions. Providing guidance to patients regarding
the avoidance of outdoor activities during periods of
high pollution is important, particularly for vulnerable
populations such as the elderly and those with pre-
existing cardiovascular disease. Additionally, patients
living in highly polluted urban areas may benefit from
the use of air purifiers and protective masks, which can
help reduce indoor pollution exposure (Pope et al.,
2016; Bell et al., 2014). These interventions are simple
yet effective strategies to help mitigate the
cardiovascular
risks
posed
by
environmental
pollutants.
On a broader scale, urban planning and public health
policies must prioritize air quality as a critical
component of cardiovascular health. Transitioning to
cleaner energy sources and electric transportation
options is essential in reducing the emissions that
contribute to urban air pollution. Expanding green
spaces and urban vegetation can also help improve air
quality by naturally filtering pollutants. In addition, the
implementation of real-time air monitoring systems,
along with public alert systems that inform residents of
pollution levels, can enable individuals to take
protective actions during periods of high pollution
exposure (Shah et al., 2013; WHO, 2021). Moreover,
stronger regulatory measures to limit emissions from
industrial and vehicular sources are crucial to reducing
the overall burden of air pollution and its associated
health risks. Public health campaigns focusing on the
cardiovascular risks of air pollution can also help raise
awareness and encourage behavior changes at the
individual and community levels.
Ultimately, addressing the intersection of urbanization,
air pollution, and cardiovascular disease requires a
multi-faceted approach that includes clinical awareness,
public health initiatives, and policy interventions. The
evidence reviewed in this article reinforces the
importance of integrating air quality concerns into
cardiovascular risk assessments, healthcare practice,
and urban policy, as these strategies will be essential in
mitigating the harmful effects of pollution on
cardiovascular health.
CONCLUSION
Urbanization is inextricably linked to air pollution, which
poses a significant and growing threat to cardiovascular
health globally. As cities continue to expand and
populations increase, the environmental challenges
associated with urban living, particularly poor air
quality, intensify. The effects of air pollution, especially
particulate matter (PM2.5) and nitrogen dioxide (NO2),
are well-documented in their capacity to contribute to
various
cardiovascular
conditions,
including
hypertension, coronary artery disease, heart attacks,
strokes, and even heart failure.
Clinical evidence strongly underscores the need for a
concerted healthcare response to address the
widespread impact of urban air pollution on heart
health. Studies show that individuals living in polluted
urban environments are at a higher risk of developing
cardiovascular diseases, and this risk is exacerbated for
vulnerable populations such as children, the elderly, and
those with pre-existing heart conditions. Moreover, the
synergistic effect of air pollution and other lifestyle
factors, such as physical inactivity and poor diet,
compounds the risk of cardiovascular diseases in urban
settings.
To mitigate these threats, it is imperative that both
healthcare professionals and policymakers work
together in a multifaceted approach. Healthcare
providers must be proactive in screening for
cardiovascular risk factors in individuals living in high-
pollution areas, adopting preventive measures, and
educating the public about the dangers of air pollution
on heart health. On the policy front, there is a critical
need for more stringent air quality regulations and
urban planning strategies that promote green spaces,
reduce traffic emissions, and prioritize sustainable
public transport. Additionally, promoting the use of
cleaner technologies and renewable energy sources will
The American Journal of Medical Sciences and Pharmaceutical Research
36
https://www.theamericanjournals.com/index.php/tajmspr
The American Journal of Medical Sciences and Pharmaceutical Research
play a pivotal role in reducing the long-term exposure
to harmful air pollutants.
Furthermore, the call for further longitudinal studies is
essential to better understand the long-term effects of
urban air pollution on cardiovascular health. Such
research will provide deeper insights into the
mechanisms by which air pollution influences heart
disease and will guide future clinical practices and
public health initiatives. Integrative strategies,
including the collaboration of medical professionals,
environmental scientists, urban planners, and
policymakers,
are
crucial
for
developing
comprehensive solutions that address the dual
challenges of urbanization and air pollution.
In conclusion, as urbanization continues to shape the
global landscape, the cardiovascular burden posed by
air pollution requires immediate attention. By
adopting a holistic approach that encompasses
healthcare interventions, effective policy measures,
and sustained research, we can significantly mitigate
the harmful effects of air pollution on heart health and
work towards creating healthier urban environments
for future generations.
REFERENCES
Bell, M. L., Ebisu, K., Leaderer, B. P., Gent, J. F., Lee, H.
J., Koutrakis, P., & Peng, R. D. (2014). Associations of
PM2.5 constituents and sources with hospital
admissions: analysis of four counties in Connecticut
and Massachusetts (USA) for persons ≥65 years of age.
Environmental Health Perspectives, 122(2), 138
–
144.
Brauer, M., Freedman, G., Frostad, J., et al. (2016).
Ambient air pollution exposure estimation for the
Global Burden of Disease 2013. Environmental Science
& Technology, 50(1), 79
–
88.
Brook, R. D., Rajagopalan, S., Pope, C. A. III, et al.
(2010). Particulate matter air pollution and
cardiovascular disease: An update to the scientific
statement from the American Heart Association.
Circulation, 121(21), 2331
–
2378.
Fuks, K. B., Weinmayr, G., Basagaña, X., et al. (2014).
Long-term exposure to ambient air pollution and traffic
noise and incident hypertension in seven cohorts of
the European study of cohorts for air pollution effects
(ESCAPE). European Heart Journal, 38(13), 983
–
990.
Kaufman, J. D., Adar, S. D., Allen, R. W., et al. (2016).
Association between air pollution and coronary artery
calcification within six metropolitan areas in the USA
(the MESA Air study): A longitudinal cohort study. The
Lancet, 388(10045), 696
–
704.
Münzel, T., Hahad, O., Kuntic, M., et al. (2017). Effects
of air pollution on the cardiovascular system. European
Heart
Journal,
38(8),
555
–
561.
https://doi.org/10.1093/eurheartj/ehw139
Newby, D. E., Mannucci, P. M., Tell, G. S., et al. (2015).
Expert position paper on air pollution and
cardiovascular disease. European Heart Journal, 36(2),
83
–
93b.
Page, M.J., McKenzie, J.E., Bossuyt, P.M., et al. (2021).
The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ, 372, n71.
https://doi.org/10.1136/bmj.n71
Pope, C. A. III, Turner, M. C., Burnett, R. T., et al. (2016).
Relationships between fine particulate air pollution,
cardiometabolic
disorders,
and
cardiovascular
mortality. Circulation Research, 119(11), 1204
–
1215.
Rajagopalan, S., Al-Kindi, S.G., & Brook, R.D. (2018). Air
pollution and cardiovascular disease: JACC state-of-the-
art review. Journal of the American College of
Cardiology,
72(17),
2054
–
2070.
https://doi.org/10.1016/j.jacc.2018.07.099
Shah, A. S. V., Lee, K. K., McAllister, D. A., et al. (2013).
Short term exposure to air pollution and stroke:
systematic review and meta-analysis. BMJ, 346, f1295.
Wilker, E. H., Mittleman, M. A., Coull, B. A., et al. (2013).
Long-term exposure to ambient air pollution and
subclinical measures of cardiovascular disease: The
Framingham Heart Study. Environmental Health
Perspectives, 121(5), 639
–
645.
World Health Organization (2021). WHO global air
quality guidelines: Particulate matter (PM2.5 and
PM10), ozone, nitrogen dioxide, sulfur dioxide and
carbon monoxide.
